abiraterone-acetate has been researched along with Parotid-Neoplasms* in 1 studies
1 other study(ies) available for abiraterone-acetate and Parotid-Neoplasms
| Article | Year |
|---|---|
Parotid gland metastasis from prostate cancer: is docetaxel still the best treatment option?
Metastases of prostate cancer originating from the parotid gland are rare. However, this presentation raises the question of the management of visceral metastasis in castration-resistant prostate cancer. We report the case of an 87-year-old man who presented with a right painless parotid mass in the context of castration-resistant prostate cancer, indicating progression of the disease. He received medical treatment based on docetaxel. Here, we discuss the impact of new hormonotherapies such as enzalutamide and abiraterone acetate, which may be used for the management of these patients. Topics: Abiraterone Acetate; Aged, 80 and over; Androstenes; Antineoplastic Agents; Benzamides; Docetaxel; Humans; Male; Nitriles; Parotid Neoplasms; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Taxoids | 2015 |